Literature DB >> 20006590

Beta tubulin affects the aryl hydrocarbon receptor function via an Arnt-mediated mechanism.

Tianmin Zhang1, Xiaodong Wang, Annie Shinn, Jingjun Jin, William K Chan.   

Abstract

We have been studying the requirement for the aryl hydrocarbon receptor nuclear translocator (Arnt)-dependent DNA complex formation, which precedes the activation of gene transcription. Using DEAE chromatography, we have obtained a Sf9 insect fraction F5 that is highly enriched with beta-tubulin. F5 inhibits the formation of the AhR gel shift complex and this inhibition is sensitive to protease, suggesting that proteins that are present in this F5 fraction are responsible for the inhibition. Additional experiments have revealed that this inhibition is less pronounced in the presence of anti-beta-tubulin IgG and beta-tubulin enriched fraction from pig brain also inhibits the AhR gel shift formation. Sf9 beta-tubulin interacts with Arnt and suppresses the binding of the AhR/Arnt heterodimer to its corresponding enhancer. Human beta4-tubulin, which shares high sequence identity with Sf9 beta-tubulin, suppresses the AhR-dependent luciferase expression by reducing the nuclear Arnt content and retaining Arnt in the cytoplasm. Fluorescence studies using the GFP fusion of human beta4-tubulin have revealed that beta4-tubulin prevents the localization of Arnt in Sf9 cells. Here we have provided evidence suggesting that beta-tubulin may regulate the physiological content of Arnt. 2009 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20006590      PMCID: PMC2823942          DOI: 10.1016/j.bcp.2009.12.010

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  21 in total

1.  Taxol-resistant epithelial ovarian tumors are associated with altered expression of specific beta-tubulin isotypes.

Authors:  M Kavallaris; D Y Kuo; C A Burkhart; D L Regl; M D Norris; M Haber; S B Horwitz
Journal:  J Clin Invest       Date:  1997-09-01       Impact factor: 14.808

2.  Both microtubule-stabilizing and microtubule-destabilizing drugs inhibit hypoxia-inducible factor-1alpha accumulation and activity by disrupting microtubule function.

Authors:  Daniel Escuin; Erik R Kline; Paraskevi Giannakakou
Journal:  Cancer Res       Date:  2005-10-01       Impact factor: 12.701

3.  BetaIII-tubulin induces paclitaxel resistance in association with reduced effects on microtubule dynamic instability.

Authors:  Kathy Kamath; Leslie Wilson; Fernando Cabral; Mary Ann Jordan
Journal:  J Biol Chem       Date:  2005-02-06       Impact factor: 5.157

4.  Involvement of cytoskeleton in AhR-dependent CYP1A1 expression.

Authors:  Zdenek Dvorák; Radim Vrzal; Jitka Ulrichová; Jean-Marc Pascussi; Patrick Maurel; Martin Modriansky
Journal:  Curr Drug Metab       Date:  2006-04       Impact factor: 3.731

Review 5.  The aryl hydrocarbon receptor cross-talks with multiple signal transduction pathways.

Authors:  Alvaro Puga; Ci Ma; Jennifer L Marlowe
Journal:  Biochem Pharmacol       Date:  2008-09-05       Impact factor: 5.858

6.  Baculovirus expression of the Ah receptor and Ah receptor nuclear translocater. Evidence for additional dioxin responsive element-binding species and factors required for signaling.

Authors:  W K Chan; R Chu; S Jain; J K Reddy; C A Bradfield
Journal:  J Biol Chem       Date:  1994-10-21       Impact factor: 5.157

7.  Microtubules-interfering agents restrict aryl hydrocarbon receptor-mediated CYP1A2 induction in primary cultures of human hepatocytes via c-jun-N-terminal kinase and glucocorticoid receptor.

Authors:  Radim Vrzal; Martine Daujat-Chavanieu; Jean-Marc Pascussi; Jitka Ulrichova; Patrick Maurel; Zdenek Dvorak
Journal:  Eur J Pharmacol       Date:  2007-12-03       Impact factor: 4.432

8.  The aryl hydrocarbon nuclear translocator alters CD30-mediated NF-kappaB-dependent transcription.

Authors:  Casey W Wright; Colin S Duckett
Journal:  Science       Date:  2009-01-09       Impact factor: 47.728

9.  Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension.

Authors:  G L Wang; B H Jiang; E A Rue; G L Semenza
Journal:  Proc Natl Acad Sci U S A       Date:  1995-06-06       Impact factor: 11.205

Review 10.  Tubulin as a target for anticancer drugs: agents which interact with the mitotic spindle.

Authors:  A Jordan; J A Hadfield; N J Lawrence; A T McGown
Journal:  Med Res Rev       Date:  1998-07       Impact factor: 12.944

View more
  3 in total

1.  Suppression of the hypoxia inducible factor-1 function by redistributing the aryl hydrocarbon receptor nuclear translocator from nucleus to cytoplasm.

Authors:  Yu Wang; Yanjie Li; Depeng Wang; Yi Li; Abraham Chang; William K Chan
Journal:  Cancer Lett       Date:  2012-02-02       Impact factor: 8.679

2.  Quantitative high-throughput profiling of environmental chemicals and drugs that modulate farnesoid X receptor.

Authors:  Chia-Wen Hsu; Jinghua Zhao; Ruili Huang; Jui-Hua Hsieh; Jon Hamm; Xiaoqing Chang; Keith Houck; Menghang Xia
Journal:  Sci Rep       Date:  2014-09-26       Impact factor: 4.379

3.  Tris (2,3-Dibromopropyl) Isocyanurate (TDBP-TAZTO or TBC) Shows Different Toxicity Depending on the Degree of Differentiation of the Human Neuroblastoma (SH-SY5Y) Cell Line.

Authors:  Konrad A Szychowski; Bartosz Skóra; Marzena Mańdziuk
Journal:  Neurotox Res       Date:  2021-08-03       Impact factor: 3.911

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.